Metrosalpingography Radioisotope

Metrosalpingography radioisotope method (RMSG) is a method for examining the uterus and its appendages using a radioactive drug that is injected into the uterine cavity through a special catheter. After the drug is administered, a scan or scintillation is performed to monitor its movement through the fallopian tubes and abdominal cavity.

Purpose of RMSG - determining the patency of the fallopian tubes, assessing the condition of the endometrium and ovaries. The method is widely used in gynecology for the diagnosis and treatment of infertility, as well as to identify the causes of ectopic pregnancy.

To conduct RMSG, it is necessary to carry out special preparation: the patient must undergo blood and urine tests, undergo an ECG and ultrasound. Anesthesia may also be required before the procedure.

After preparation, the doctor injects a radiopharmaceutical into the uterine cavity and monitors its movement through the fallopian tubes and abdominal cavity. The scanning time depends on the chosen research method (scanning or scintigraphy).

Advantages of RMSG:

1. High diagnostic accuracy;
2. Possibility of assessing the condition of the endometrium;
3. Determination of patency of the fallopian tubes;
4. Assessment of the condition of the ovaries.

However, like any other research method, RMSG has its drawbacks. These include:

1. Risk of allergic reactions to the radiopharmaceutical;
2. The need to use anesthesia;
3. Age and health restrictions.

In general, RMSG is one of the most accurate methods for examining the uterus and appendages. It is widely used in gynecological practice for the diagnosis and treatment of various diseases associated with the reproductive system.

Radioisotope metrosalpingography is one of the most modern and effective methods for diagnosing diseases of the female reproductive system using isotopes. It allows you to visualize and examine the condition of the uterus, fallopian tubes, ovaries and pelvic organs. This method is relevant when planning pregnancy, identifying the causes of infertility, preventing reproductive pathologies and assessing the effectiveness of cancer treatment. The method is based on the intravenous administration of the drug "Tetsebroma", which consists of iodine, which is slowly distributed in the body. The composition of the drug